The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Isabella Pacchiarotti,David J. Bond,Ross J. Baldessarini,Willem A. Nolen,Heinz Grunze,Rasmus Wentzer Licht,Robert M. Post,Michael Berk,Guy M. Goodwin,Gary S. Sachs,Leonardo Tondo,Robert L. Findling,Eric A. Youngstrom,Mauricio Tohen,Juan Undurraga,Ana González-Pinto,Joseph F. Goldberg,Aysegul Yildiz,Lori L. Altshuler,Joseph R. Calabrese,Philip B. Mitchell,Michael E. Thase,Athanasios Koukopoulos,Francesc Colom,Mark A. Frye,Gin S Malhi,Konstantinos N. Fountoulakis,Gustavo H. Vázquez,Roy H. Perlis,Terence A. Ketter,Frederick Cassidy,Hagop S. Akiskal,Jean-Michel Azorin,Marc Valentí,Diego Hidalgo Mazzei,Beny Lafer,Tadafumi Kato,Lorenzo Mazzarini,Anabel Martínez-Arán,Gordon Parker,Daniel Souery,Ayşegül Özerdem,Susan L. McElroy,Paolo Girardi,Michael Bauer,Lakshmi N. Yatham,Carlos A. Zarate,Andrew A. Nierenberg,Boris Birmaher,Shigenobu Kanba,Rif S. El-Mallakh,Alessandro Serretti,Zoltán Rihmer,Allan H. Young,Georgios D. Kotzalidis,Glenda MacQueen,Charles L. Bowden,S. Nassir Ghaemi,Carlos López-Jaramillo,Janusz K. Rybakowski,Kyooseob Ha,Giulio Perugi,Siegfried Kasper,Jay D. Amsterdam,Robert M. A. Hirschfeld,Flávio Kapczinski,Eduard Vieta +66 more
Reads0
Chats0
TLDR
A consensus was reached on 12 statements on the use of antidepressants in bipolar disorder, and antidepressants should be prescribed only as an adjunct to mood-stabilizing medications.Abstract:
A task force report presents 12 recommendations for antidepressant use in bipolar disorder rated by at least 80% of International Society for Bipolar Disorders experts as essential or important.read more
Citations
More filters
Journal ArticleDOI
Suicide prevention strategies revisited: 10-year systematic review
Gil Zalsman,Gil Zalsman,Keith Hawton,Danuta Wasserman,Kees van Heeringen,Ella Arensman,Marco Sarchiapone,Vladimir Carli,Cyril Höschl,Ran Barzilay,Judit Balazs,György Purebl,Jean-Pierre Kahn,Pilar A. Saiz,Cendrine Bursztein Lipsicas,Julio Bobes,Doina Cozman,Ulrich Hegerl,Joseph Zohar +18 more
TL;DR: The evidence for restricting access to lethal means in prevention of suicide has strengthened since 2005, especially with regard to control of analgesics and hot-spots for suicide by jumping.
Journal ArticleDOI
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
Guy M. Goodwin,Peter M. Haddad,I. N. Ferrier,Jeffrey K Aronson,T R H Barnes,Andrea Cipriani,David Coghill,Seena Fazel,John R. Geddes,Heinz Grunze,Emily A. Holmes,Oliver D. Howes,S. Hudson,N. Hunt,Ian Jones,Iain Macmillan,H. McAllister-Williams,D. R. Miklowitz,Richard Morriss,Marcus R. Munafò,Carol Paton,B. J. Saharkian,Kate E. A. Saunders,Julia Sinclair,David Taylor,Eduard Vieta,Allan H. Young +26 more
TL;DR: The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.
Journal ArticleDOI
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N. Yatham,Sidney H. Kennedy,Sagar V. Parikh,Ayal Schaffer,David J. Bond,Benicio N. Frey,Verinder Sharma,Benjamin I. Goldstein,Soham Rej,Serge Beaulieu,Martin Alda,Glenda MacQueen,Roumen Milev,Arun V. Ravindran,Claire O'Donovan,Diane McIntosh,Raymond W. Lam,Gustavo Vazquez,Flávio Kapczinski,Roger S. McIntyre,Jan Marie Kozicky,Shigenobu Kanba,Beny Lafer,Trisha Suppes,Joseph R. Calabrese,Eduard Vieta,Gin S Malhi,Robert M. Post,Michael Berk +28 more
TL;DR: These 2018 CANMAT and ISBD Bipolar Treatment Guidelines represent the significant advances in the field since the last full edition was published in 2005, including updates to diagnosis and management as well as new research into pharmacological and psychological treatments.
Journal ArticleDOI
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S Malhi,Darryl Bassett,Philip Boyce,Richard A. Bryant,Paul B. Fitzgerald,Kristina Fritz,Malcolm Hopwood,Bill Lyndon,Roger T. Mulder,Greg Murray,Richard J Porter,Ajeet B. Singh +11 more
TL;DR: The Mood Disorder CPG is the first Clinical Practice Guideline to address both depressive and bipolar disorders and provides up-to-date recommendations and guidance within an evidence-based framework, supplemented by expert clinical consensus.
Journal ArticleDOI
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Anthony J. Cleare,Carmine M. Pariante,Allan H. Young,Ian M. Anderson,D M B Christmas,Philip J. Cowen,Chris Dickens,I. N. Ferrier,John R. Geddes,Simon Gilbody,Peter M. Haddad,Cornelius Katona,Glyn Lewis,Andrea Malizia,RH McAllister-Williams,Paul Ramchandani,Jan Scott,David Taylor,Rudolf Uher +18 more
TL;DR: These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse and stopping treatment.
References
More filters
Journal ArticleDOI
Assessing the quality of reports of randomized clinical trials : is blinding necessary?
Alejandro R. Jadad,R. A. Moore,Dawn Carroll,C. Jenkinson,David Reynolds,David J. Gavaghan,Henry J McQuay +6 more
TL;DR: An instrument to assess the quality of reports of randomized clinical trials (RCTs) in pain research is described and its use to determine the effect of rater blinding on the assessments of quality is described.
Journal ArticleDOI
Consensus methods for medical and health services research.
Jeremy Jones,Duncan Hunter +1 more
TL;DR: Two consensus methods commonly adopted in medical, nursing, and health services research--the Delphi process and the nominal group technique (also known as the expert panel)--are described, together with the most appropriate situations for using them.
Journal ArticleDOI
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Lakshmi N. Yatham,Sidney H. Kennedy,Sagar V. Parikh,Ayal Schaffer,Serge Beaulieu,Martin Alda,Claire O'Donovan,Glenda MacQueen,Roger S. McIntyre,Verinder Sharma,Arun V. Ravindran,L. Trevor Young,Roumen Milev,David J. Bond,Benicio N. Frey,Benjamin I. Goldstein,Beny Lafer,Boris Birmaher,Kyooseob Ha,Willem A. Nolen,Michael Berk,Michael Berk +21 more
TL;DR: The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009, and this third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunctionWith the previous publications.
Journal ArticleDOI
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
Guy M. Goodwin,Peter M. Haddad,I. N. Ferrier,Jeffrey K Aronson,T R H Barnes,Andrea Cipriani,David Coghill,Seena Fazel,John R. Geddes,Heinz Grunze,Emily A. Holmes,Oliver D. Howes,S. Hudson,N. Hunt,Ian Jones,Iain Macmillan,H. McAllister-Williams,D. R. Miklowitz,Richard Morriss,Marcus R. Munafò,Carol Paton,B. J. Saharkian,Kate E. A. Saunders,Julia Sinclair,David Taylor,Eduard Vieta,Allan H. Young +26 more
TL;DR: The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.
Journal ArticleDOI
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Gary S. Sachs,Andrew A. Nierenberg,Joseph R. Calabrese,Lauren B. Marangell,Stephen R. Wisniewski,Laszlo Gyulai,Edward S. Friedman,Charles L. Bowden,Mark D. Fossey,Michael J. Ostacher,Terence A. Ketter,Jayendra K. Patel,Peter Hauser,Daniel Rapport,James M. Martinez,Michael H. Allen,David J. Miklowitz,Michael W. Otto,Ellen B. Dennehy,Michael E. Thase +19 more
TL;DR: The use of adjunctive, standard antidepressant medication, as compared with the use of mood stabilizers, was not associated with increased efficacy or with increased risk of treatment-emergent affective switch.
Related Papers (5)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Lakshmi N. Yatham,Sidney H. Kennedy,Sagar V. Parikh,Ayal Schaffer,Serge Beaulieu,Martin Alda,Claire O'Donovan,Glenda MacQueen,Roger S. McIntyre,Verinder Sharma,Arun V. Ravindran,L. Trevor Young,Roumen Milev,David J. Bond,Benicio N. Frey,Benjamin I. Goldstein,Beny Lafer,Boris Birmaher,Kyooseob Ha,Willem A. Nolen,Michael Berk,Michael Berk +21 more
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
Guy M. Goodwin,Peter M. Haddad,I. N. Ferrier,Jeffrey K Aronson,T R H Barnes,Andrea Cipriani,David Coghill,Seena Fazel,John R. Geddes,Heinz Grunze,Emily A. Holmes,Oliver D. Howes,S. Hudson,N. Hunt,Ian Jones,Iain Macmillan,H. McAllister-Williams,D. R. Miklowitz,Richard Morriss,Marcus R. Munafò,Carol Paton,B. J. Saharkian,Kate E. A. Saunders,Julia Sinclair,David Taylor,Eduard Vieta,Allan H. Young +26 more